<DOC>
	<DOCNO>NCT00751140</DOCNO>
	<brief_summary>The primary objective show perform lymph node dissection may detect occult nodal metastasis patient population whereby provide important diagnostic information , potential therapeutic benefit patient isolate nodal metastasis . In case urothelial carcinoma upper urinary tract ( cancer originate inner line urinary tract ) require removal kidney , ureter , cuff bladder ( surgical term nephroureterectomy ) . Previous study urothelial carcinoma bladder , show lymph node dissection ( surgically remove lymph node ) may improve survival , least give idea patient may need chemotherapy ( drug control cancer cell outside kidney-ureter ) early ( node enlarge image study ) .</brief_summary>
	<brief_title>Merits Performing Modified Template Retroperitoneal Lymph Node Dissection</brief_title>
	<detailed_description>Participants nephroureterectomy ( take kidney ureter ) . Investigators also lymph node dissection ( take patient 's lymph node side kidney ) look malignancy outside kidney ureter . The lymph node send pathology review . Study visit schedule 10 14 day surgery removal stitch analysis patient 's pathology report . The following procedure do : - History physical examination , urinary cytology ( test look malignant cell urine ) surveillance cystoscopy ( procedure look inside urethra bladder perform office local anesthesia ) every 3 month first 2 year treatment , every 6 month next 2 year yearly thereafter patient free recurrence . - Radiographic study include chest x-ray abdomino-pelvic compute tomography ( CAT scan ) perform every 6 month first 2 year yearly thereafter . - Bone scan ( special imaging study look cancer spread bone ) case bone pain elevate alkaline phosphatase level . After surgery patient follow every 3 month first 2 year treatment , every 6 month next 2 year yearly thereafter free recurrence .</detailed_description>
	<mesh_term>Urologic Neoplasms</mesh_term>
	<criteria>Patients suspect transitional cell carcinoma upper urinary tract deem surgical candidate Negative visible retroperitoneal perihilar lymphadenopathy preoperative radiographic study . Defined absence suspicious abdominal , retroperitoneal , pelvic lymphadenopathy ( define &gt; 1 centimeter [ cm ] ) preoperative radiographic imaging ( Abdominal pelvic compute tomography [ CT ] magnetic resonance image [ MRI ] CT contraindicate ) . Imaging study do Moffitt local facility patient 's choice . All image study go review Moffitt . Note : Nodal involvement depend size lymph node enlargement ; usually nod 2 cm associate malignancy . With threshold 1cm , false negative rate microscopic metastasis low ( 4 % ) false positive rate 3 43 % accord literature . Because aim study perform lymph node dissection patient nonmetastatic disease base preoperative evaluation , 1 cm threshold use . Nodes 1 cm consider positive patient exclude mention protocol . Biopsy include part protocol potential patient node 1 cm exclude . No suspected site metastasis preoperative radiographic image Patients visible lymph node metastasis preoperative radiographic study . Defined &gt; 1cm abdominal , retroperitoneal pelvic lymphadenopathy Patients suspect site distant metastasis preoperative imaging . ( Patients suspect bony metastasis require bone scan . ) Patients suspect transitional cell carcinoma upper urinary tract significant comorbidities make nonsurgical candidate Patients nontransitional cell carcinoma upper urinary tract exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>surgical candidate</keyword>
	<keyword>upper urinary tract</keyword>
	<keyword>urothelial carcinoma</keyword>
	<keyword>lymph node dissection</keyword>
</DOC>